| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/08/2002 | US20020106746 Nucleotide sequences coding preferential protein for use in the treatment of septic shock, liver and immunological, tumors and connective tissue defects |
| 08/08/2002 | US20020106743 IL-17 homologous polypeptides and therapeutic uses thereof |
| 08/08/2002 | US20020106742 Nucleic acids encoding active and inactive CCR5 chemokine receptors |
| 08/08/2002 | US20020106741 Nucleotide sequences coding membrane protein for use in the treatment of psychological and nervous system disorders |
| 08/08/2002 | US20020106740 Nucleotide sequences coding membrane protein for use in treatment asthma, Parkinson's disease, heart defects, hypotension, urogenital disorders and osteoporosis |
| 08/08/2002 | US20020106739 Modified G-protein coupled receptors |
| 08/08/2002 | US20020106738 Novel Siglec gene |
| 08/08/2002 | US20020106737 Polypeptide for use in the diagnosis, prevention and treatment of cancer, cellular differentiation, immunological and coagulation defects; wound healing agents |
| 08/08/2002 | US20020106736 Nucleotide sequences coding membrane protein for use in the treatment of autoimmune, rheumatoid disease, dibates, multiple sclerosis, Sjogren's syndome, glomerulonephritis and myasthenia gravis |
| 08/08/2002 | US20020106735 Novel Bcl-2 related proline rich protein (BPR) |
| 08/08/2002 | US20020106734 Adrenergic receptor |
| 08/08/2002 | US20020106732 Smad6 and uses thereof |
| 08/08/2002 | US20020106731 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of apoptosis and inflammation defects |
| 08/08/2002 | US20020106730 B7-H2 molecules, novel members of the B7 family and uses thereof |
| 08/08/2002 | US20020106728 NS4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 08/08/2002 | US20020106727 Polypeptide for use in the treatment of cancer |
| 08/08/2002 | US20020106726 Peptide for use in the treatment of inflammation defects |
| 08/08/2002 | US20020106724 RNA-binding protein |
| 08/08/2002 | US20020106723 Receptor for latrotoxin from insects |
| 08/08/2002 | US20020106722 Novel compounds |
| 08/08/2002 | US20020106721 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 08/08/2002 | US20020106720 Cre-inducible expression system |
| 08/08/2002 | US20020106719 Generation of preferential proteins in cell free system; obtain cell extract, incubate with nucleotide sequences, expose to translational organelles, recover processed proteins |
| 08/08/2002 | US20020106717 Detecting bacterial propagation polypeptide; obtain bacteria, suspend in isotonic solution, centrifuge, incubae with ammonium sulfate, centrifuge, dissolve pellet, dry pellet, solubilize, expose to spectrum analysis |
| 08/08/2002 | US20020106703 Screening cell pool for pancreatic progenitor cells; obtain mammalian cell culture, incubate with marker protein, detect those cells bound by marker protein |
| 08/08/2002 | US20020106694 Use of computer to designing preferential polypeptides; obtain computer, input polypeptide sequence data, adjust polypeptide sequence data, analyse potential activities associated with adjustment |
| 08/08/2002 | US20020106690 The g-protein b subunit interaction domain of ste20p/pak family of protein kinases and uses thereof in bioassays |
| 08/08/2002 | US20020106689 Detecting immunological defects in mammal; obtain sample tissue from mammal, detect proteasome activity, reduction in proteasome activty indicates immunological defect |
| 08/08/2002 | US20020106678 cDNA clones encoding human G protein gamma subunits |
| 08/08/2002 | US20020106676 Nucleotide sequence coding preferential protein for use in the treatment of nervous system disorders |
| 08/08/2002 | US20020106671 Identification of a capacitative calcium channel in antigen presenting cells and uses thereof |
| 08/08/2002 | US20020106669 Enzymatic polypeptide for use as tool in amplifying energy efficiency in bacteria |
| 08/08/2002 | US20020106664 Tapasin-like protein |
| 08/08/2002 | US20020106660 Crystal structure of the 30s ribosome and its use |
| 08/08/2002 | US20020106656 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of kidney and tumor disorders |
| 08/08/2002 | US20020106655 Nucleotide sequences coding preferential protein for use in the treatment, diagnosis and prevention of immunological, nervous system and tumor disorders |
| 08/08/2002 | US20020106652 Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex |
| 08/08/2002 | US20020106650 Nucleotide sequence coding preferential polypeptide; for use in the treatment, prevention and diagnosis of kidney, liver, reproductive and cardiovascular disorders |
| 08/08/2002 | US20020106641 Nucleotide sequences coding viral protein for use in vaccinations and veterinary medicine |
| 08/08/2002 | US20020106640 Peptide for use in the treatment and prevention of viral infection |
| 08/08/2002 | US20020106639 Postweaning multisystemic wasting syndrome virus from pigs |
| 08/08/2002 | US20020106636 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| 08/08/2002 | US20020106635 Cytokine resistant cytomegalovirus promoter mutants and related products and methods |
| 08/08/2002 | US20020106630 Method of identifying HIBEF51 receptor inhibitors |
| 08/08/2002 | US20020106380 rSOWgp58 protein and its use as an antigen |
| 08/08/2002 | US20020106379 Viral vaccines based on the engineered viruses |
| 08/08/2002 | US20020106378 Materials and methods for intracellular transport and their uses |
| 08/08/2002 | US20020106377 Compositions and methods for detecting adult Taenia solium |
| 08/08/2002 | US20020106376 Vaccines |
| 08/08/2002 | US20020106375 Non-cytolytic soluble factor from activated-expanded CD4 cells |
| 08/08/2002 | US20020106374 Compositions and methods for inhibition of HIV-1 infection |
| 08/08/2002 | US20020106373 Proteins associated with EGF signaling |
| 08/08/2002 | US20020106372 Anti-TNF antibodies and peptides of human tumor necrosis factor |
| 08/08/2002 | US20020106371 For therapy of sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura |
| 08/08/2002 | US20020106370 Improvements in or relating to peptide delivery |
| 08/08/2002 | US20020106362 Method for the treatment of chemonucleolysis |
| 08/08/2002 | US20020106356 Secreted proteins |
| 08/08/2002 | US20020106355 Novel regulatory sequences of the MCP-1 gene |
| 08/08/2002 | US20020106350 Methods for therapy of neurodegenerative disease of the brain |
| 08/08/2002 | US20020106333 Enamel matrix related polypeptide |
| 08/08/2002 | US20020106323 Natural killer cell enhancing factor C |
| 08/08/2002 | CA2472051A1 Zis-sr nucleic acid and amino acid sequences involved in the regulated secretory pathway and/or the regulation of the neuroendocrine phenotype (nep) |
| 08/08/2002 | CA2437021A1 Adiponectin-associated protein |
| 08/08/2002 | CA2437016A1 Screening method for infection agent of prion disease |
| 08/08/2002 | CA2436748A1 Method of using a variant of vegf receptor to treat psoriasis and to enhance wound healing |
| 08/08/2002 | CA2436661A1 Novel nucleic acid and polypeptide molecules |
| 08/08/2002 | CA2436610A1 Protein kinase signalling |
| 08/08/2002 | CA2436530A1 Environmentally regulated genes of streptococcus suis |
| 08/08/2002 | CA2436411A1 Methods for treating or preventing skin disorders using cd2-binding agents |
| 08/08/2002 | CA2436281A1 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 08/08/2002 | CA2434953A1 Protein modification and maintenance molecules |
| 08/08/2002 | CA2434822A1 Haemophilus influenza basb212 polynucleotides, polypeptides and use thereof |
| 08/08/2002 | CA2434293A1 Fluorescent proteins |
| 08/08/2002 | CA2434097A1 Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor viii |
| 08/08/2002 | CA2432867A1 A novel human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
| 08/08/2002 | CA2432731A1 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 08/08/2002 | CA2432278A1 Methods and compositions relating to cardiac-specific nuclear regulatory factors |
| 08/08/2002 | CA2430921A1 Use of a vector encoding a ghrh peptide to enhance growth in multiple litters of offspring from female animals |
| 08/08/2002 | CA2428248A1 Solubility reporter gene constructs |
| 08/08/2002 | CA2427143A1 Compositions and methods for improving kidney function |
| 08/08/2002 | CA2426856A1 Thuja plicata dirigent protein promoters |
| 08/08/2002 | CA2426818A1 Control of gene expression in plants |
| 08/08/2002 | CA2426582A1 Gene delivery formulations and methods for treatment of ischemic conditions |
| 08/07/2002 | EP1229132A2 Human ralgds-like protein 3 |
| 08/07/2002 | EP1229122A2 Chimeric isoprenoid synthases and uses thereof |
| 08/07/2002 | EP1229119A1 PHOTOSENSITIVITY GENE Hd1 OF PLANT AND UTILIZATION THEREOF |
| 08/07/2002 | EP1229118A1 Photosensitivity gene of plant and utilization thereof |
| 08/07/2002 | EP1229117A2 Crystals of the human TRAIL/sDR5 (TNF-related apoptosis-inducing ligand/extracellular domain of DR5 receptor) complex, their three-dimensional structure and uses thereof |
| 08/07/2002 | EP1229115A1 Novel c-type lectin and gene thereof |
| 08/07/2002 | EP1229114A1 Gene encoding protein capable of regenerating luciferin, novel recombinant dna and process for producing protein capable of regenerating luciferin |
| 08/07/2002 | EP1229048A1 Thromboplastin reagent and method for manufacturing the same |
| 08/07/2002 | EP1229047A2 IL-1 Receptor fusion proteins used as antagonists and methods of making and using |
| 08/07/2002 | EP1229046A2 Human testis expressed patched like protein |
| 08/07/2002 | EP1229045A1 Universal carrier for targeting molecules to Gb3 receptor expressing cells |
| 08/07/2002 | EP1229044A1 Protein having multiple antigen/epitope sequences and being immobilized for the diagnosis of HIV infections |
| 08/07/2002 | EP1229043A1 Peptides derived from Epstein Barr virus (EBV) proteins LMP1, LMP2 and BARF1 antibody reagents reactive therewith |
| 08/07/2002 | EP1228373A2 Diagnosis and therapy of cancer using sgp28-related molecules |
| 08/07/2002 | EP1228235A1 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 08/07/2002 | EP1228234A2 Production of chimeric capsid vectors |
| 08/07/2002 | EP1228233A2 Methods and compositions comprising renilla gfp |